Form 4 for ELVN Enliven Therapeutics, Inc.

Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-18 · accession 0001209191-22-012399 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-02-23	2022-02-18+	ELVN	MOTT DAVID M	Dir	P - Purchase	$1.45	+151.5K	194.0K	+356%	+$219.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-02-23	P	A	35,257	$1.46	229,224	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F4) Open market purchases reported on this line occurred at a weighted average price of $1.46 (range $1.39 to $1.50).
2	Common	Common Stock	2022-02-18	P	A	50,398	$1.30	128,150	D	—	—	(F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market purchases reported on this line occurred at a weighted average price of $1.30 (range $1.23 to $1.38).
3	Common	Common Stock	2022-02-22	P	A	65,817	$1.56	193,967	D	—	—	(F3) Open market purchases reported on this line occurred at a weighted average price of $1.56 (range $1.44 to $1.60). (F2) Mr. Mott undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.